Literature DB >> 2732242

Expression and tissue-specific assembly of human butyrylcholine esterase in microinjected Xenopus laevis oocytes.

H Soreq1, S Seidman, P A Dreyfus, D Zevin-Sonkin, H Zakut.   

Abstract

Cholinesterases represent a ubiquitous, polymorphic family of acetylcholine hydrolyzing enzymes. The multileveled tissue-specific heterogeneity which characterizes these enzymes makes the cholinesterases an appropriate model for studying the mechanisms involved in regulating divergent pathways in protein biogenesis. For this purpose, a cDNA coding for human butyrylcholine esterase (BuChE) was subcloned into the SP 6 transcription vector. Synthetic mRNA transcribed from this construct was microninjected into Xenopus laevis oocytes alone, and in conjunction with poly(A)+ RNAs extracted from human brain or muscle. Injected BuChE-mRNA induced the biosynthesis of a protein exhibiting the catalytic activity, substrate specificity, and sensitivity to selective inhibitors characteristic of native human serum BuChE, and clearly distinct from the related enzyme acetylcholinesterase (AChE). The nascent BuChE was reproducibly distributed into low salt-soluble and detergent-extractable pools. Sucrose gradient analysis demonstrated that the nascent human enzyme was capable of limited subunit assembly, appearing as functional dimeric molecules in both of these fractions. Co-injection with brain or muscle-derived mRNAs facilitated higher order oligomeric assembly. Co-injected brain mRNA induced the appearance of tetramers while co-injected muscle mRNA induced the appearance of an array of heavy molecular forms, including a heavy 16 S form. These results indicate that the molecular determinants which distinguish BuChE from AChE are inherent to its primary amino acid sequence and that additional, tissue-specific protein(s) are involved in the modulation of subunit assembly within particular biological milieues.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2732242

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Manipulations of cholinesterase gene expression modulate murine megakaryocytopoiesis in vitro.

Authors:  D Patinkin; S Seidman; F Eckstein; F Benseler; H Zakut; H Soreq
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

2.  Molecular cloning and construction of the coding region for human acetylcholinesterase reveals a G + C-rich attenuating structure.

Authors:  H Soreq; R Ben-Aziz; C A Prody; S Seidman; A Gnatt; L Neville; J Lieman-Hurwitz; E Lev-Lehman; D Ginzberg; Y Lipidot-Lifson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  Cholinesterases in cellular and molecular neurobiology.

Authors: 
Journal:  Cell Mol Neurobiol       Date:  1991-02       Impact factor: 5.046

4.  Improving poor in vitro transcription from G,C-rich genes.

Authors:  R Ben Aziz; H Soreq
Journal:  Nucleic Acids Res       Date:  1990-06-11       Impact factor: 16.971

Review 5.  Amplification of butyrylcholinesterase and acetylcholinesterase genes in normal and tumor tissues: putative relationship to organophosphorous poisoning.

Authors:  H Soreq; H Zakut
Journal:  Pharm Res       Date:  1990-01       Impact factor: 4.200

6.  Acetylcholinesterase and butyrylcholinesterase genes coamplify in primary ovarian carcinomas.

Authors:  H Zakut; G Ehrlich; A Ayalon; C A Prody; G Malinger; S Seidman; D Ginzberg; R Kehlenbach; H Soreq
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

7.  Recombinant human acetylcholinesterase is secreted from transiently transfected 293 cells as a soluble globular enzyme.

Authors:  B Velan; C Kronman; H Grosfeld; M Leitner; Y Gozes; Y Flashner; T Sery; S Cohen; R Ben-Aziz; S Seidman
Journal:  Cell Mol Neurobiol       Date:  1991-02       Impact factor: 5.046

8.  Intramolecular relationships in cholinesterases revealed by oocyte expression of site-directed and natural variants of human BCHE.

Authors:  L F Neville; A Gnatt; Y Loewenstein; S Seidman; G Ehrlich; H Soreq
Journal:  EMBO J       Date:  1992-04       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.